Ligand Pharmaceuticals (LGNYZ) Leases (2019 - 2025)
Historic Leases for Ligand Pharmaceuticals (LGNYZ) over the last 7 years, with Q3 2025 value amounting to $7.6 million.
- Ligand Pharmaceuticals' Leases rose 631.55% to $7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.6 million, marking a year-over-year increase of 631.55%. This contributed to the annual value of $9.7 million for FY2024, which is 5956.78% up from last year.
- According to the latest figures from Q3 2025, Ligand Pharmaceuticals' Leases is $7.6 million, which was up 631.55% from $8.0 million recorded in Q2 2025.
- Over the past 5 years, Ligand Pharmaceuticals' Leases peaked at $32.1 million during Q3 2022, and registered a low of $800000.0 during Q1 2025.
- In the last 5 years, Ligand Pharmaceuticals' Leases had a median value of $9.7 million in 2024 and averaged $11.9 million.
- As far as peak fluctuations go, Ligand Pharmaceuticals' Leases skyrocketed by 29341.77% in 2021, and later plummeted by 8672.86% in 2025.
- Quarter analysis of 5 years shows Ligand Pharmaceuticals' Leases stood at $16.2 million in 2021, then plummeted by 75.31% to $4.0 million in 2022, then skyrocketed by 51.55% to $6.1 million in 2023, then skyrocketed by 59.57% to $9.7 million in 2024, then dropped by 21.34% to $7.6 million in 2025.
- Its Leases was $7.6 million in Q3 2025, compared to $8.0 million in Q2 2025 and $800000.0 in Q1 2025.